Rubric Capital Management LP

Holdings History for Coherus Oncology, Inc. - Common Stock, par value $0.0001 per share (CHRS)

Symbol: CHRS on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 5,258,754 shares
Security Ownership %: 4.6%

Shares, Excluding Options vs Price

Value, Excluding Options

Rubric Capital Management LP ownership in Coherus Oncology, Inc. Common Stock, par value $0.0001 per share (CHRS)

13 Feb 2025 - Rubric Capital Management LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,258,754 shares of Coherus Oncology, Inc. Common Stock, par value $0.0001 per share (CHRS). This represents 4.6% ownership of the company. This is the first filing by Rubric Capital Management LP disclosing ownership of Coherus Oncology, Inc. Common Stock, par value $0.0001 per share (CHRS).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Rubric Capital Management LP	4.6%		$5,258,754	5,258,754			$1.00	13G/A	31 Dec 2024	13 Feb 2025, 16:01

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025			-0.01%	$0	0	-867,800	-100%	$2.22	Q3 2025
30 Jun 2025		0.01%	-0.05%	$634,622	867,800	-4,390,954	-83%	$0.73	Q2 2025
31 Mar 2025		0.08%	0%	$4,243,814	5,258,754	0		$0.81	Q1 2025
31 Dec 2024		0.13%	-0.13%	$7,257,081	5,258,754	-5,141,246	-49%	$1.38	Q4 2024
30 Sep 2024		0.18%	0%	$10,816,000	10,400,000	0		$1.04	Q3 2024
30 Jun 2024		0.47%	0%	$17,992,000	10,400,000	0		$1.73	Q2 2024
31 Mar 2024		0.73%	+0.71%	$24,856,000	10,400,000	+10,004,793	+2532%	$2.39	Q1 2024
31 Dec 2023		0.05%	+0.05%	$1,316,039	395,207	+395,207	NEW	$3.33	Q4 2023
30 Jun 2020			-4.2%	$0	0	-1,583,061	-100%	$2.22	Q2 2020
31 Mar 2020		4.2%	-1.4%	$25,677,000	1,583,061	-543,019	-26%	$16.22	Q1 2020
31 Dec 2019		4.5%	+0.19%	$38,280,000	2,126,080	+88,550	+4.3%	$18.00	Q4 2019
30 Sep 2019		4.6%	+3%	$41,280,000	2,037,530	+1,337,530	+191%	$20.26	Q3 2019
30 Jun 2019		1.7%	-4.6%	$15,470,000	700,000	-1,940,771	-73%	$22.10	Q2 2019
31 Mar 2019		3.4%	-0.53%	$36,020,000	2,640,771	-409,229	-13%	$13.64	Q1 2019
31 Dec 2018		3.4%	+2.7%	$27,603,000	3,050,000	+2,420,000	+384%	$9.05	Q4 2018
30 Sep 2018		1.1%	+0.5%	$10,395,000	630,000	+288,510	+84%	$16.50	Q3 2018
30 Sep 2018	call		-65%	$0	0	-350,000	-100%	$2.22	Q3 2018
30 Jun 2018		0.47%	-0.17%	$4,781,000	341,490	-121,906	-26%	$14.00	Q2 2018
30 Jun 2018	call	65%	+65%	$4,900,000	350,000	+350,000	NEW	$14.00	Q2 2018
31 Mar 2018		0.48%	+0.48%	$5,121,000	463,396	+463,396	NEW	$11.05	Q1 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.